Level of self-reported psychological and physical complaints
Psychological scales . | Control subjects . | Type 1 diabetic patients . | Mean dif (95% CI) . |
---|---|---|---|
SCL-90-R | |||
Total Score | 116.1 ± 4.04 | 121.6 ± 4.04 | 5.59 (−6.10 to 17.27) |
Anxiety | 12.34 ± 0.44 | 12.76 ± 0.44 | 0.42 (−0.86 to 1.69) |
Agoraphobia | 7.87 ± 0.32 | 7.93 ± 0.32 | 0.00 (−0.86 to 0.97) |
Depression | 20.56 ± 0.84 | 22.34 ± 0.84 | 1.79 (−0.63 to 4.20)* |
Somatization | 18.30 ± 0.84 | 18.95 ± 0.84 | 0.65 (−1.77 to 3.07) |
Cognitive performance difficulty | 12.55 ± 0.58 | 14.53 ± 0.58 | 1.98 (0.30–3.65)* |
Interpersonal sensitivity and paranoid ideation | 21.92 ± 0.88 | 24.21 ± 0.88 | 2.28 (−0.27 to 4.84) |
Anger-hostility | 6.33 ± 0.29 | 7.49 ± 0.29 | 1.16 (0.33–1.99)* |
Sleep disturbance | 5.42 ± 0.45 | 6.04 ± 0.45 | 0.63 (−0.69 to 1.94) |
BDI-II | 3.96 ± 0.72 | 5.73 ± 0.71 | 1.76 (−0.32 to 3.85) |
Psychological scales . | Control subjects . | Type 1 diabetic patients . | Mean dif (95% CI) . |
---|---|---|---|
SCL-90-R | |||
Total Score | 116.1 ± 4.04 | 121.6 ± 4.04 | 5.59 (−6.10 to 17.27) |
Anxiety | 12.34 ± 0.44 | 12.76 ± 0.44 | 0.42 (−0.86 to 1.69) |
Agoraphobia | 7.87 ± 0.32 | 7.93 ± 0.32 | 0.00 (−0.86 to 0.97) |
Depression | 20.56 ± 0.84 | 22.34 ± 0.84 | 1.79 (−0.63 to 4.20)* |
Somatization | 18.30 ± 0.84 | 18.95 ± 0.84 | 0.65 (−1.77 to 3.07) |
Cognitive performance difficulty | 12.55 ± 0.58 | 14.53 ± 0.58 | 1.98 (0.30–3.65)* |
Interpersonal sensitivity and paranoid ideation | 21.92 ± 0.88 | 24.21 ± 0.88 | 2.28 (−0.27 to 4.84) |
Anger-hostility | 6.33 ± 0.29 | 7.49 ± 0.29 | 1.16 (0.33–1.99)* |
Sleep disturbance | 5.42 ± 0.45 | 6.04 ± 0.45 | 0.63 (−0.69 to 1.94) |
BDI-II | 3.96 ± 0.72 | 5.73 ± 0.71 | 1.76 (−0.32 to 3.85) |
Data are adjusted means ± SE. Mean dif: the adjusted between group differences (type 1 diabetic patients − control subjects) in the univariate ANOVA. All scores are adjusted for estimated premorbid IQ and sex. Higher scores reflect more reported complaints.
P < 0.05.